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Abstract
Background: Fistula formation has been reported in intraductal papillary-mucinous neoplasms
(IPMNs) with or without invasion of the adjacent organs. The presence or absence of invasion is
mostly determined by postoperative histological examination rather than by preoperative work-up.
Case presentation: A 72 year-old Japanese woman showed remarkable dilatation of the main
pancreatic duct (MPD) in the distal region of the pancreas. Subsequent ERCP also showed MPD
dilatation, after which the patient suffered moderate pancreatitis. A subsequent gastroscopy
revealed a small ulceration that had not been observed in a gastroscopy performed 3 months prior.
Mucinous discharge from the ulceration suggested it might be the orifice of a fistula connected to
the MPD. En bloc resection including the distal region of the pancreas, spleen, stomach and part of
the transverse colon was performed under the pre- and intraoperative diagnosis of an invasive
malignant IPMN. However, histopathology revealed the lesion to be of "borderline malignancy"
without apparent invasion of the stomach. Light microscopy showed inflammatory cellular
infiltrates (mainly neutrophils) around the pancreatogastric fistula, but there was no evidence of
neoplastic epithelia lining the fistulous tract.
Conclusion:  This case highlights that a pancreatogastric fistula can develop after acute
inflammation of the pancreas in the absence of cancer invasion. Further information regarding
IPMN-associated fistulae is necessary to clarify the pathogenesis, diagnosis, appropriate surgical
intervention and prognosis for this disorder.
Background
Intraductal papillary-mucinous neoplasms (IPMNs) of
the pancreas have unique clinico-pathological characteris-
tics and show a wide spectrum of histological types, rang-
ing from adenomatous hyperplasia to invasive cancer.
While non-invasive IPMNs show slow growth and good
prognosis after resection, the outcome can become poor if
they transform into invasive ductal cancers. There are
three types of IPMN: main duct,, branch, and combined.
Published: 19 October 2005
World Journal of Surgical Oncology 2005, 3:70 doi:10.1186/1477-7819-3-70
Received: 03 June 2005
Accepted: 19 October 2005
This article is available from: http://www.wjso.com/content/3/1/70
© 2005 Koizumi et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.World Journal of Surgical Oncology 2005, 3:70 http://www.wjso.com/content/3/1/70
Page 2 of 5
(page number not for citation purposes)
The main duct and combined types are associated with
higher rates of invasive cancer than the branch type [1].
A feature of IPMNs is occasional fistula formation with
surrounding organs such as the duodenum, bile ducts,
stomach and even the peritoneal or pleural cavity [2-10].
While such fistula formation is generally thought to be
associated with invasive IPMNs, some non-invasive
IPMNs also form fistulas. Thus, IPMN fistula formation
raises intriguing issues concerning pathogenesis, diagno-
sis and patient prognosis.
We report here a rare non-invasive "borderline-malig-
nant" IPMN that formed a pancreatogastric fistula. Fistula
formation was triggered by acute pancreatitis following
endoscopic retrograde cholangiopancreatography
(ERCP).
Case presentation
A 72 year-old Japanese woman underwent abdominal
ultrasonography (US) as part of a routine physical
checkup in April 2001. This procedure incidentally
detected marked dilatation of the main pancreatic duct
(MPD) in the distal region of the pancreas. Magnetic res-
onance cholangiopancreatography (MRCP) and abdomi-
nal computed tomography (CT) showed MPD dilatation
and a multi-lobular cystic lesion. ERCP confirmed these
findings, and no extraluminal leakage of the contrast
medium was observed (Figure 1). Cytology on pancreatic
fluid indicated non-neoplastic epithelia. Endoscopic
ultrasonography (EUS) identified 8 mm papillary projec-
tions in the cystic lesion, which was a key indication for
surgery. A routine gastroscopy performed simultaneously
with EUS showed no significant findings.
Following the ERCP, the patient complained of abdomi-
nal pain and showed hyperamylasemia and leukocytosis.
Distinct swelling of the pancreas and thickening of the
gastric wall were subsequently observed by abdominal CT
(Figure 2), which indicated a mild post-ERCP pancreatitis.
Gastroscopy performed for the assessment of gastric wall
thickness revealed a small ulceration in the body of the
stomach (Figure 3), which was accompanied by a muci-
nous discharge suggesting the presence of a fistula open-
ing into the MPD. These findings, along with abdominal
angiography data indicating encasement of the splenic
artery suggested a malignant invasion into the stomach by
the primary lesion. All other laboratory data, including
tumor marker expression (e.g., CEA and CA19-9), were
within normal limits.
A laparotomy was performed 1 month after the ERCP.
Firm fibrous tissue between the pancreas and the mesente-
rium of the transverse colon suggested the pancreatic neo-
plasm was of an invasive nature. An en bloc resection of the
distal pancreas, spleen, stomach and part of the transverse
colon was performed. Postoperative histopathology
showed the distal pancreas had an IPMN whose lining
epithelia showed only "borderline-malignancy" and no
apparent invasion of adjacent tissues or organs. Light
ERCP on presentation showing a dilated MPD and cystic  lesions in the distal region of the pancreas Figure 1
ERCP on presentation showing a dilated MPD and cystic 
lesions in the distal region of the pancreas.
Abdominal CT just prior to surgery showing distinct swelling  of the pancreas and the gastric wall, causing the border  between the two organs to be unclear Figure 2
Abdominal CT just prior to surgery showing distinct swelling 
of the pancreas and the gastric wall, causing the border 
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microscopy examination revealed inflammatory cellular
infiltration consisting mainly of neutrophils around a
pancreatogastric fistula which had no neoplastic epithelia
(Figure 4). The patient was discharged after an uneventful
postoperative recovery and showed no signs of recurrence
3 years after surgery.
Discussion
Fistula formation associated with an IPMN was first
reported by Ohhashi et al in 1980 as a pancreatobiliary
fistula [2]. Since then there have been 41 cases reported
between 1980 and 2004 (Table 1) [3-9]. According to
these reports, the organs most frequently affected by
fistula formation were the duodenum (24 cases, 59%),
common bile duct (21 cases, 51%) and stomach (7 cases,
17%). Apparent cancer invasion was the main cause of the
fistulae in 16 cases (37%), while similar to the present
case, 17 cases (41%) showed fistulae into neighboring
organs in the absence of tumor invasion (Table 2). Five of
the six previous IPMN cases associated with pancreatogas-
tric fistulae were linked to apparent cancer invasion.
To our knowledge, the present report is only the second
describing a case of IPMN associated with pancreatogas-
tric fistulae without invasive cancer. Yago et al reported a
rare case of non-invasive intraductal papillary adenocarci-
noma of the pancreas that was associated with develop-
ment of a pancreatogastric fistula in the absence of cancer
invasion [5]. In that case, neoplastic epithelia were
observed only on the surface of the fistula and gastric
mucosa, while the structure of the gastric wall beside the
fistula was maintained without invasive cancer. Those
authors speculated that the pancreatogastric fistula devel-
oped due to high pressure in the MPD. Baek et al and
Watanabe et al reported the same phenomenon in muci-
nous cystic tumors (MCTs) [11,12]. The mechanism of
such fistula formation without cancer spread could be
explained by a combination of high pressure in the MPD
and inflammatory stimulation [3,4,13].
In the present case, ERCP played a key role in fistula for-
mation. To our knowledge, this is the first report to show
an absence of a pancreatogastric fistula immediately prior
to ERCP, and then the presence of a fistula following post-
ERCP pancreatitis. Post-ERCP pancreatitis, which is
reported to occur in approximately 1.8–10% of patients,
should be carefully investigated in IPMN cases [14,15].
We emphasize here that development of an IPMN-associ-
ated fistula does not necessarily represent underlying
invasive cancer. Fistula formation can result in an incor-
rect preoperative diagnosis of invasive cancer and lead to
the undertaking of unnecessary surgical procedures.
Although the lesion in the present case was a non-invasive
tumor, surgery was appropriate given the indications of
invasive cancer. While non-invasive IPMNs have a good
prognosis, there remains the possibility of dissemination
by tumor penetration. When treating IPMNs associated
Gastroscopy just prior to surgery showing a small ulcer pro- ducing a mucinous discharge into the body of the stomach Figure 3
Gastroscopy just prior to surgery showing a small ulcer pro-
ducing a mucinous discharge into the body of the stomach.
A cross-section of the pancreatogastric fistula (Hematoxylin  and Eosin stain × 40) Figure 4
A cross-section of the pancreatogastric fistula (Hematoxylin 
and Eosin stain × 40). The fistula was significantly infiltrated 
with neutrophils and showed no evidence of neoplastic 
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with fistula, the extent of resection should depend on the
extent of cancer invasion. To avoid dissemination, the fis-
tula should be removed independent to cancer invasion.
The extent of resection of affected organs should be indi-
vidually determined based on the results of preoperative
images and precise intraoperative histological
examinations.
Conclusion
The present case highlights that a pancreatogastric fistula
can develop in the absence of invasive cancer. Further data
regarding IPMN-associated fistulae are necessary in order
to clarify the pathogenesis, diagnosis, appropriate surgical
intervention and prognosis for this disorder.
Table 1: Published cases of developing fistulae from IPMNs (1980–2004)
No. Author Year Affected Organs Cancer Invasion Pathological 
Diagnosis
1 Ohhashi [2] 1980 C - cystadenocarcinoma
2 Koike [3] 1980 C, D unknown pap
3 Sukisaki [3] 1984 S, D + pap (+ muc)
4 Usui [3] 1985 D - pap
5 Suyama [3] 1986 C + pap
6 Suyama [3] 1986 D + pap
7 Yamao [3] 1986 D unknown pap
8 Yamao [3] 1986 C unknown pap
9 Yamao [3] 1986 C unknown pap
10 Miyagawa [3] 1988 C, D + pap (+ muc)
11 Kuga [3] 1988 D - pap
12 Tohyama [3] 1989 C - pap
13 Nakajima [3] 1989 C - pap
14 Ohnuma [3] 1990 S + pap (+ muc)
15 Sakimoto [3] 1991 C + pap (+ muc)
16 Mayumi [3] 1991 C, D + muc (+ pap)
17 Hayashi [3] 1991 C unknown cystadenocarcinoma
18 Oda [3] 1993 C, D - pap
19 Saitoh [3] 1993 C - pap
20 Kobayashi [4] 1993 S + muc (+ pap)
21 Kobayashi [4] 1993 S, D + muc (+ pap)
22 Kobayashi [4] 1993 C, D unknown pap
23 Kobayashi [4] 1993 D unknown pap
24 Kobayashi [4] 1993 D unknown muc (+ pap)
25 Mori [3] 1994 C + pap
26 Ieda [3] 1995 D + tub
27 Yago [5] 1995 S - pap
28 Takekuma [3] 1996 D - pap
29 Nakamura [3] 1996 C, D + pap
30 Murata [3] 1996 C, D - pap
31 Hirota [3] 1996 D - pap
32 Tadokoro [6] 1996 D - unknown
33 Nakatsuka [3] 1997 S, D + muc
34 Matsubayashi [7] 1998 D + pap
35 Kawaharada [3] 1999 D + pap
36 Kawaharada [3] 1999 D + pap
37 Shiroko [8] 2000 C, D - unknown
38 Kurihara [9] 2000 C - pap
39 Kurihara [9] 2000 C - pap
40 Fujisawa [3] 2001 C - pap
41 Koizumi(present case) 2004 S - low grade malignancy
Affected Organ; C: Common bile duct, D: Duodenum, S: Stomach
Pathological Diagnosis; pap: papillary carcinoma, muc: mucinous carcinoma
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Cancer invasion
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Affected Organ; C: Common bile duct, D: Duodenum, S: Stomach